Pharmaceutical composition
PH12021552500B1Active Publication Date: 2026-11-06ASTELLAS PHARMA INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12021552500
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-10-01
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2041-10-01
Abstract
Provided is a pharmaceutical composition containing 6-ethyl-3-{3-methoxy-4-[4-(4methylpiperazin-1-yl)piperidin-1-yl]anilino}-5-[(oxan-4-yl)amino]pyrazine-2carboxamide or a pharmaceutically acceptable salt thereof and a sweetener for reducing the bitterness of gilteritinib, suppressing the decrease in dissolution stability of gilteritinib due to, for example, stress such as heat and / or humidity over time, and having excellent dissolution stability. The pharmaceutical composition contains gilteritinib or a pharmaceutically acceptable salt thereof, a sweetener, and sugars and / or sugar alcohols.
Need to check novelty before this filing date? Find Prior Art
